(Q34035015)

English

Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

quality of life

1 reference

based on heuristic

inferred from title

Jurgen Vercauteren

object named as

Jurgen Vercauteren

5

0 references

object named as

Jolie Ringash

14

0 references

Andrew Bottomley

19

object named as

Andrew Bottomley

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Charles S Cleeland

6

object named as

Charles S Cleeland

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

8

object named as

Carolyn Gotay

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Martin Taphoorn

17

object named as

Martin J Taphoorn

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

object named as

Corneel Coens

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Francesca Martinelli

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Chantal Quinten

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

John T Maringwa

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Henning Flechtner

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Eva Greimel

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Madeleine King

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Tito Mendoza

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David Osoba

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Bryce B Reeve

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Joseph Schmucker-Von Koch

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Qiuling Shi

16

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Joachim Weis

18

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

European Organisation for Research and Treatment of Cancer Clinical Groups

20

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Expert Review of Pharmacoeconomics & Outcomes Research

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

587-599

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Symptom clusters in cancer patients.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Occurrence of symptom clusters

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Symptom clusters: the new frontier in symptom management research

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Symptom clusters in patients with advanced cancers.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Symptom clusters related to treatment for prostate cancer

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Health related quality of life outcomes in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gas

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group.

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Factor analysis of the psychosocial items of the EORTC QLQ-C30 in metastatic breast cancer patients participating in a psychosocial intervention study

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Symptom clusters in cancer patients: a review of the literature

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Missing quality of life data in cancer clinical trials: serious problems and challenges

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

External validity of a randomised clinical trial of temporomandibular disorders: analysis of the patients who refused to participate in research

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1586%2FERP.11.51

21 January 2018

Identifiers

10.1586/ERP.11.51

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34035015&oldid=2015153882"